H.R. 2821

119th CongressPassed House

FDA Modernization Act 3.0

Sponsored by Earl L. "Buddy" Carter (Republican-GA-1)

Healthcare & Public Health Pharmaceutical Policy Public Health Infrastructure & Data

Cosponsors

Actions

Roll calls

Amendments

Related bills

Actions

Jul 20, 2026 · House floor actions

Mr. Guthrie moved to suspend the rules and pass the bill.

Jul 20, 2026 · House floor actions

Considered under suspension of the rules.

Jul 20, 2026 · House floor actions

DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.

Jul 20, 2026 · Library of Congress

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.

Jul 20, 2026 · House floor actions

On motion to suspend the rules and pass the bill Agreed to by voice vote.

Jul 20, 2026 · House floor actions

Motion to reconsider laid on the table Agreed to without objection.

Jun 18, 2026 · Library of Congress

Reported by the Committee on Energy and Commerce. H. Rept. 119-706.

Jun 18, 2026 · House floor actions

Reported by the Committee on Energy and Commerce. H. Rept. 119-706.

Jun 18, 2026 · House floor actions

Placed on the Union Calendar, Calendar No. 614.

May 21, 2026 · House committee actions

Committee Consideration and Mark-up Session Held

May 21, 2026 · House committee actions

Ordered to be Reported by the Yeas and Nays: 44 - 0.

May 13, 2026 · House committee actions

Subcommittee Consideration and Mark-up Session Held

May 13, 2026 · House committee actions

Forwarded by Subcommittee to Full Committee by Voice Vote.

Apr 10, 2026 · House committee actions

Referred to the Subcommittee on Health.

Apr 10, 2025 · Library of Congress

Introduced in House

Apr 10, 2025 · Library of Congress

Introduced in House

Apr 10, 2025 · House floor actions

Referred to the House Committee on Energy and Commerce.

Latest activity

Activity

July 2026

Lobbying reported · Animal Wellness Action · Jul 20

Animal Wellness Action reported 2nd Quarter (Apr 1 - June 30) lobbying for Animal Wellness Action

BillsH.R. 1477 H.R. 1661 H.R. 2539 H.R. 2821 H.R. 3683 H.R. 3946 H.R. 4422 S. 355 S. 1236 S. 1454

Lobbying reported · National Association For Biomedical Research · Jul 20

National Association For Biomedical Research reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association For Biomedical Research — $30,000

BillsH.R. 2821 H.R. 7567 H.R. 8800 S. 4172

Lobbying reported · The Personal Care Products Council · Jul 20

The Personal Care Products Council reported 2nd Quarter (Apr 1 - June 30) lobbying for Personal Care Products Council (PCPC) — $140,000

BillsH.R. 1657 H.R. 2269 H.R. 2821 H.R. 2853 H.R. 4390 H.R. 4433 H.R. 6832 H.R. 7205 S. 355 S. 1092 S. 1404

Lobbying reported · Holland & Knight · Jul 20

Holland & Knight reported 1st Quarter (Jan 1 - Mar 31) lobbying for Public Access To Sunscreens (pass) Coalition — $100,000

BillsH.R. 2821 S. 355

Lobbying reported · Holland & Knight · Jul 20

Holland & Knight reported 2nd Quarter (Apr 1 - June 30) lobbying for Public Access To Sunscreens (pass) Coalition — $110,000

BillsH.R. 2821 S. 355

Lobbying reported · Consumer Healthcare Products Association (CHPA) · Jul 14

Consumer Healthcare Products Association (CHPA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Consumer Healthcare Products Association (CHPA) — $199,750

BillsH.R. 1 H.R. 1219 H.R. 2821 H.R. 3686 H.R. 3722 H.R. 4273 H.R. 4958 H.R. 5027 H.R. 5371 H.R. 6868 H.R. 7291 H.R. 7366 H.R. 8370 H.R. 8385 H.R. 8933 S. 355 S. 2292 S. 2529 S. 3788 S. 4587

You’re all caught up.